S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NASDAQ:ARNA

Arena Pharmaceuticals SEC Filings & 10K Form

$73.26
-3.55 (-4.62 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$68.92
Now: $73.26
$74.08
50-Day Range
$74.24
MA: $79.65
$83.95
52-Week Range
$32.95
Now: $73.26
$90.19
Volume1.39 million shs
Average Volume500,133 shs
Market Capitalization$4.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.83

SEC Filings

Arena Pharmaceuticals (NASDAQ:ARNA) SEC Filings

DateFilerForm TypeView
03/02/2021
3:50 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
3:15 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2021
8:02 PM
Arena Pharmaceuticals (Issuer)
Ouzren Nawal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
8:01 PM
Arena Pharmaceuticals (Issuer)
Ouzren Nawal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/18/2021
8:00 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
5:18 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/12/2021
7:08 AM
Arena Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G
02/10/2021
9:30 AM
Arena Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/04/2021
7:57 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
7:56 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4/A
01/20/2021
8:06 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
8:05 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
7:43 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
8:19 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
8:18 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
8:17 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
8:10 AM
Arena Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/11/2021
8:02 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
3:07 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
3:03 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
3:02 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
3:02 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2020
3:02 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2020
3:01 PM
Arena Pharmaceuticals (Issuer)
Cabell Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2020
3:00 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2020
3:00 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
11:56 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
3:31 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
3:10 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2020
7:31 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
8:00 AM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
8:00 AM
Arena Pharmaceuticals (Filer)
Garrett Motion Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2020
12:30 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
7:41 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
4:21 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:01 PM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2020
4:23 PM
Arena Pharmaceuticals (Issuer)
Cabell Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:28 PM
Arena Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/19/2020
4:25 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:24 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:24 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:24 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:23 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:21 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:20 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:17 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/19/2020
4:14 PM
Arena Pharmaceuticals (Filer)
Form S-8 POS
06/18/2020
4:07 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:54 PM
Arena Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:48 PM
Arena Pharmaceuticals (Issuer)
Nova Tina Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:46 PM
Arena Pharmaceuticals (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:45 PM
Arena Pharmaceuticals (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:42 PM
Arena Pharmaceuticals (Issuer)
GALLAHUE KIERAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:41 PM
Arena Pharmaceuticals (Issuer)
FETZER OLIVER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:40 PM
Arena Pharmaceuticals (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:38 PM
Arena Pharmaceuticals (Issuer)
Knobil Katharine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:27 PM
Arena Pharmaceuticals (Issuer)
Knobil Katharine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/16/2020
6:25 PM
Arena Pharmaceuticals (Issuer)
Cabell Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:23 PM
Arena Pharmaceuticals (Issuer)
Cabell Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/16/2020
3:39 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
4:22 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2020
5:40 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
5:34 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
3:47 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
3:44 PM
Arena Pharmaceuticals (Filer)
Form 424B5
05/27/2020
3:13 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
6:31 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:46 PM
Arena Pharmaceuticals (Filer)
Form DEFA14A
04/01/2020
3:06 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
7:24 AM
Arena Pharmaceuticals (Issuer)
Schmidt Joan (Reporting)
Form 4/A
03/17/2020
5:47 PM
Arena Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
5:43 PM
Arena Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2020
5:42 PM
Arena Pharmaceuticals (Issuer)
Schmidt Joan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:25 PM
Arena Pharmaceuticals (Issuer)
Schmidt Joan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/03/2020
5:17 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:15 PM
Arena Pharmaceuticals (Issuer)
Klassen Preston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:13 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:10 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
5:02 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
6:43 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
6:40 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
6:37 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
7:02 AM
Arena Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/27/2020
2:11 PM
Arena Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/13/2020
3:12 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
3:50 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
4:44 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
7:14 PM
Arena Pharmaceuticals (Issuer)
WOODS RANDALL E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
7:02 AM
Arena Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2019
7:22 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:21 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:20 PM
Arena Pharmaceuticals (Issuer)
Klassen Preston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:19 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:18 PM
Arena Pharmaceuticals (Issuer)
Lind Kevin Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
7:17 PM
Arena Pharmaceuticals (Issuer)
Munshi Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
8:05 PM
Arena Pharmaceuticals (Issuer)
Aurentz Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
8:03 PM
Arena Pharmaceuticals (Issuer)
SPECTOR STEVEN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:05 PM
Arena Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2019
5:59 PM
Arena Pharmaceuticals (Issuer)
Lisicki Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/17/2019
5:56 PM
Arena Pharmaceuticals (Issuer)
WOODS RANDALL E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.